952 related articles for article (PubMed ID: 29609136)
1. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
[TBL] [Abstract][Full Text] [Related]
2. Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study.
Lin M; Liu C; Liu Y; Wang D; Zheng C; Shi X; Chen Z; Liu J; Li X; Yang S; Li Z
Ann Nutr Metab; 2019; 74(4):287-295. PubMed ID: 30965331
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.
Liu CQ; He CM; Chen N; Wang D; Shi X; Liu Y; Zeng X; Yan B; Liu S; Yang S; Li X; Li X; Li Z
Sci Rep; 2016 Dec; 6():38605. PubMed ID: 27924915
[TBL] [Abstract][Full Text] [Related]
4. Serum fetuin-B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: A cross-sectional study.
Wang D; Liu Y; Liu S; Lin L; Liu C; Shi X; Chen Z; Lin M; Yang S; Li Z; Li X
J Diabetes; 2018 Jul; 10(7):581-588. PubMed ID: 29194974
[TBL] [Abstract][Full Text] [Related]
5. Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes.
El-Ashmawy HM; Ahmed AM
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):859-864. PubMed ID: 30601337
[TBL] [Abstract][Full Text] [Related]
6. Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults.
Li Z; He C; Liu Y; Wang D; Lin M; Liu C; Shi X; Chen Z; Li X; Yang S; Li W
J Atheroscler Thromb; 2020 May; 27(5):418-428. PubMed ID: 31527322
[TBL] [Abstract][Full Text] [Related]
7. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
8. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study.
Zhu J; Wan X; Wang Y; Zhu K; Li C; Yu C; Li Y
Endocrine; 2017 Apr; 56(1):208-211. PubMed ID: 27628583
[TBL] [Abstract][Full Text] [Related]
9. Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease.
Yamasandhi PG; Dharmalingam M; Balekuduru A
Indian J Gastroenterol; 2021 Dec; 40(6):556-562. PubMed ID: 34950996
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
11. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
12. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.
Ebert T; Linder N; Schaudinn A; Busse H; Berger J; Lichtinghagen R; Keim V; Wiegand J; Karlas T
Endocrine; 2017 Nov; 58(2):246-252. PubMed ID: 28914407
[TBL] [Abstract][Full Text] [Related]
13. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes.
Cernea S; Roiban AL; Both E; Huţanu A
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3050. PubMed ID: 30052309
[TBL] [Abstract][Full Text] [Related]
15. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease.
Hossain IA; Akter S; Bhuiyan FR; Shah MR; Rahman MK; Ali L
BMC Res Notes; 2016 May; 9():266. PubMed ID: 27169860
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients.
Hua X; Li M; Pan F; Xiao Y; Cui W; Hu Y
Sci Rep; 2017 Nov; 7(1):14532. PubMed ID: 29109457
[TBL] [Abstract][Full Text] [Related]
17. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.
Barchetta I; Cimini FA; Leonetti F; Capoccia D; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
J Clin Endocrinol Metab; 2018 Jun; 103(6):2253-2260. PubMed ID: 29590379
[TBL] [Abstract][Full Text] [Related]
18. [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].
Chellali S; Boudiba A; Griene L; Koceir EA
Ann Biol Clin (Paris); 2019 Jun; 77(3):261-271. PubMed ID: 30998190
[TBL] [Abstract][Full Text] [Related]
19. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
20. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
